Annual report pursuant to Section 13 and 15(d)

Consolidated Financial Statement Detail (Tables)

v3.3.1.900
Consolidated Financial Statement Detail (Tables)
12 Months Ended
Dec. 31, 2015
Consolidated Financial Statement Detail [Abstract]  
Trade and other receivables

Trade and other receivables consisted of the following (in thousands):

 

 

 

December 31,

 

 

 

2015

 

 

2014

 

Trade receivables, net

 

$

3,718

 

 

$

2,993

 

Other receivables

 

 

351

 

 

 

316

 

Total

 

$

4,069

 

 

$

3,309

 

 

Property and equipment, net

Property and equipment, net consisted of the following (in thousands):

 

 

 

December 31,

 

 

 

2015

 

 

2014

 

Equipment and furniture

 

$

14,431

 

 

$

28,638

 

Buildings, leasehold and building improvements

 

 

2,776

 

 

 

9,343

 

Construction-in-progress

 

 

243

 

 

 

337

 

Land

 

 

 

 

 

310

 

 

 

 

17,450

 

 

 

38,628

 

Less:  Accumulated depreciation and amortization

 

 

(15,453

)

 

 

(33,508

)

Property and equipment, net

 

$

1,997

 

 

$

5,120

 

 

Accrued and other liabilities

Accrued and other liabilities consisted of the following (in thousands):

 

 

 

December 31,

 

 

 

2015

 

 

2014

 

Accrued management incentive compensation

 

$

2,609

 

 

$

4,295

 

Accrued payroll and other benefits

 

 

2,156

 

 

 

3,061

 

Accrued legal and accounting fees

 

 

517

 

 

 

409

 

Accrued restructuring costs

 

 

459

 

 

 

 

Accrued clinical trial costs

 

 

406

 

 

 

1,424

 

Other

 

 

878

 

 

 

703

 

Total

 

$

7,025

 

 

$

9,892